These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6410671)

  • 1. Cerebrotendinous xanthomatosis: clinical and laboratory study of 2 cases.
    Canelas HM; Quintão EC; Scaff M; Vasconcelos KS; Brotto MW
    Acta Neurol Scand; 1983 May; 67(5):305-11. PubMed ID: 6410671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type IIa hyperlipoproteinemia masquerading as cerebrotendinous xanthomatosis.
    Ijichi S; Ijichi N; Niina K; Kuriyama M; Izumo S; Nakamura F; Osame M
    J Neurol Sci; 1989 Dec; 94(1-3):101-5. PubMed ID: 2614461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric disorders in patients with cerebrotendinous xanthomatosis.
    Berginer VM; Foster NL; Sadowsky M; Townsend JA; Siegel GJ; Salen G
    Am J Psychiatry; 1988 Mar; 145(3):354-7. PubMed ID: 3344851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of cerebrotendinous xanthomatosis with massive xanthomas but without a considerable increase in serum cholestanol levels.
    Takahashi M; Okazaki H; Tada H; Ishibashi S
    J Clin Lipidol; 2023; 17(6):834-838. PubMed ID: 37777472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of cerebrotendinous xanthomatosis: effects of ursodeoxycholic acid administration on serum bile acids and cholestanol.
    Kimura S; Beppu T; Kugai N; Koide Y; Fujita T; Iida K; Yamashita N; Yamashita K; Seyama Y
    Jpn J Med; 1982 Jul; 21(3):210-5. PubMed ID: 7143816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrotendinous xanthomatosis in three siblings from a Taiwanese family.
    Chang WN; Kuriyama M; Lui CC; Jeng SF; Chen WJ; Chee EC
    J Formos Med Assoc; 1992 Dec; 91(12):1190-4. PubMed ID: 1363642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cerebrotendinous xanthomatosis--a case of brain MRI abnormality and osteoporosis].
    Kubota R; Nakagawa M; Nakamura A; Kuriyama M; Osame M
    Rinsho Shinkeigaku; 1992 May; 32(5):488-93. PubMed ID: 1333927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrotendinous xanthomatosis.
    Kearns WP; Wood WS
    Arch Ophthalmol; 1976 Jan; 94(1):148-50. PubMed ID: 1247403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrotendinous cholestanolosis in relation to other cerebral xanthomatoses.
    de Jong JG; van Gent CM; Delleman JW
    Clin Neurol Neurosurg; 1977; 79(4):253-72. PubMed ID: 200389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Magnetic resonance of the brain and Achilles tendon in cerebrotendinous xanthomatosis].
    Pardo J; Prieto JM; Rodríguez JR; Vadillo J; Dapena MD; Noya M
    Neurologia; 1993 Oct; 8(8):268-70. PubMed ID: 8240840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations.
    Moghadasian MH; Salen G; Frohlich JJ; Scudamore CH
    Arch Neurol; 2002 Apr; 59(4):527-9. PubMed ID: 11939886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cerebrotendinous xanthomatosis].
    Berginer VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(4):13-22. PubMed ID: 1333699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrotendinous xanthomatosis: a defect in cellular sterol biosynthetic control.
    Barron JL; Maxwell JU; Rutherfoord GS
    J Inherit Metab Dis; 1982; 5(2):91-3. PubMed ID: 6820431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosynthesis of 5 -cholestan-3 -ol in cerebrotendinous xanthomatosis.
    Salen G; Polito A
    J Clin Invest; 1972 Jan; 51(1):134-40. PubMed ID: 4550120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis.
    Salen G; Grundy SM
    J Clin Invest; 1973 Nov; 52(11):2822-35. PubMed ID: 4355999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
    Salen G; Shefer S; Tint GS
    Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis.
    Nakamura T; Matsuzawa Y; Takemura K; Kubo M; Miki H; Tarui S
    Metabolism; 1991 Jul; 40(7):741-6. PubMed ID: 1908036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cerebrotendinous xanthomatosis: a multicentric retrospective study of 15 adults, clinical and paraclinical typical and atypical aspects].
    Lionnet C; Carra C; Ayrignac X; Levade T; Gayraud D; Castelnovo G; Besson G; Androdias G; Vukusic S; Confavreux C; Zaenker C; De Seze J; Collongues N; Blanc F; Tranchant C; Wallon D; Hannequin D; Gerdelat-Mas A; Brassat D; Clanet M; Zephir H; Outteryck O; Vermersch P; Labauge P
    Rev Neurol (Paris); 2014; 170(6-7):445-53. PubMed ID: 24746394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging of cerebrotendinous xanthomatosis.
    Tai KS; Brockwell J; Chan FL; Janus ED; Lam KS
    Australas Radiol; 1995 Feb; 39(1):61-5. PubMed ID: 7695531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholestanol deposition in cerebrotendinous xanthomatosis. A possible mechanism.
    Salen G
    Ann Intern Med; 1971 Dec; 75(6):843-51. PubMed ID: 5134895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.